Home › Funds › Yiheng Capital Management, L.P. › DBVT
Yiheng Capital Management, L.P. position in DBVT
DBV TECHNOLOGIES S A · Health Care
Yiheng Capital Management, L.P. reported holding 170,142 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 1.27% of its reported portfolio and ranking #21 among its reported holdings. Yiheng Capital Management, L.P. has disclosed DBVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Yiheng Capital Management, L.P.'s DBVT position evolved
Yiheng Capital Management, L.P. first disclosed a stake in DBVT in Q3 2023 at 133,192 shares (US$181K). The position peaked in Q4 2025 at 639,769 shares, worth US$12.3M. Across 12 filings, Yiheng Capital Management, L.P. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 170,142 shares valued at US$2.8M. Notable position changes include a 3835% increase in Q4 2023 (shares fell 21% over the following quarter), a 79% trim in Q4 2024 (shares rose 121% over the following quarter), a 73% trim in Q1 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 133.19K | $181.14K | New |
| Q4 2023 | 5.24M | $4.99M | Add |
| Q1 2024 | 5.57M | $4.17M | Add |
| Q2 2024 | 3.15M | $2.53M | Reduce |
| Q3 2024 | 3.15M | $2.21M | Hold |
| Q4 2024 | 656.31K | $2.03M | Reduce |
| Q1 2025 | 656.31K | $4.48M | Hold |
| Q2 2025 | 656.31K | $6.01M | Hold |
| Q3 2025 | 656.31K | $6.56M | Hold |
| Q4 2025 | 639.77K | $12.26M | Reduce |
| Q1 2026 | 170.14K | $3.55M | Reduce |
| Q2 2026 | 170.14K | $2.79M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DBVT and 13F data
DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DBVT
- MPM BioImpact LLC 3.67M sh · $60.13M · Q2 2026
- Siren, L.L.C. 1.86M sh · $30.46M · Q2 2026
- Vivo Capital, LLC 1.84M sh · $30.25M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.65M sh · $27.11M · Q2 2026
- Logos Global Management LP 915.00K sh · $15.01M · Q2 2026
- Patient Square Capital LP 909.47K sh · $14.92M · Q2 2026
- Octagon Capital Advisors LP 574.20K sh · $9.42M · Q2 2026
- Redmile Group, LLC 410.44K sh · $6.73M · Q2 2026
- Elmind Capital, LP 265.00K sh · $4.35M · Q2 2026
- Ishara Investments LP 184.50K sh · $3.03M · Q2 2026
- GREAT POINT PARTNERS LLC 156.91K sh · $2.57M · Q2 2026
More on Yiheng Capital Management, L.P.
FAQ
How long has Yiheng Capital Management, L.P. held DBVT?
Yiheng Capital Management, L.P. has disclosed DBVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Yiheng Capital Management, L.P.'s current position in DBVT?
As of Q2 2026, Yiheng Capital Management, L.P. holds 170.14K shares of DBVT (DBV TECHNOLOGIES S A), valued at $2.79M, representing 1.27% of its reported portfolio and ranking #21.
Has Yiheng Capital Management, L.P. been buying or selling DBVT?
In the latest 13F filing (Q2 2026), Yiheng Capital Management, L.P. held unchanged its position in DBVT. The position peaked in Q4 2025 at 639.77K shares.
Which other funds hold DBVT?
Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.